6th Age-Related Disease Therapeutics Summit Hyatt Centric Fisherman’s Wharf San Francisco, San Francisco
In 2024, age-related disease biotechs are set to shine, building on 2023’s milestones such as Eli Lilly’s partnership with BioAge to test muscle rejuvenation therapy and Chan Zuckerberg Biolabs tapping into immune cell engineering to eradicate age-related diseases.
To successfully navigate the volatile market of 2024, rapid proof-of-concept studies and validated clinical endpoints are crucial for funding and pipeline progress.
The 6th Age-Related Disease Therapeutics Summit is returning to San Francisco in June, with 60+ participants including Eli Lilly, Takeda, and Turn Biosciences to dive deep into breakthroughs in cellular programming, senolytic pathways, and epigenetic effects. Explore biomarkers, navigate regulations, and foster collaborations for pipeline support and commercialization.
This is your definitive age-related disease therapeutics forum to gain unparalleled competitive intelligence, scientific advancements and form meaningful partnerships to solve humankind’s fundamental problem.
⌛ Event Dates & Venue
👨👧👦 Social Networks
💸 Website & Tickets
Go to Event Website Conference + 2 Workshops - Drug Developer Pricing: USD 3797.00, Conference + 1 Workshop - Drug Developer Pricing: USD 3398.00, Conference Only - Drug Developer Pricing: USD 2999.00, Conference + 2 Workshops - Solution Provider Pricing: USD 4631.00, Conference + 1 Workshop - Solution Provider Pricing: USD 4166.00, Conference Only - Solution Provider Pricing: USD 3699.00
Advertisements
Similar events
5th Annual International Conference on Spirituality and Psychology 2022 IMG Health, Wealth, and Community Expo 18th International Conference on Otolaryngology: ENT Surgery 
21st Annual Emergency Medicine Symposium: A Practical Update 
3rd Annual Mayo Clinic Specialty Updates for the Generalist Team 2024 The CMS Hospital Infection Prevention, Control and Antibiotic Stewardship Program – CMS Compliance Requirements 2023